itinai content

  • AI News
  • AI Sales
  • Apple AI
  • Biohacking
  • Clinical Trials
  • Compare
  • Computer Vision
  • DeepSense
  • farma
  • Instruments
  • Management
  • Marketing
  • Marktechpost
  • Open AI
  • resume
  • КП
  • Three Meeting Red Flags That Skilled Leaders Notice

    20 июня, 2025

    Matt Harrison Clough Have your meetings become routine? The underlying dynamics of meetings often go unnoticed and unchecked. But savvy leaders run meetings like elite sports coaches choregraph games using a series of plays. These leaders scan for potentially destructive meeting red flags and seize subtle opportunities to enhance team success and individual growth. In… →

    Management
  • From Backend Automation to Frontend Collaboration: What’s New in AG-UI Latest Update for AI Agent-User Interaction

    20 июня, 2025

    «`html From Backend Automation to Frontend Collaboration: What’s New in AG-UI Latest Update for AI Agent-User Interaction Introduction AI agents are increasingly moving from pure backend automators to visible, collaborative elements within modern applications. However, making agents genuinely interactive—capable of both responding to users and proactively guiding workflows—has long been an engineering headache. Each team… →

    AI News
  • First-in-human phase 1 study of KHK2455 monotherapy and in combination with mogamulizumab in patients with advanced solid tumors

    20 июня, 2025

    CONCLUSIONS: KHK2455 + mogamulizumab was safe and well tolerated with manageable toxicities, and resulted in dose-dependent suppression of IDO1 activity; signals of antitumor activity were observed. →

    Clinical Trials
  • An examination of imaging findings in patients with clinically diagnosed gluteal tendinopathy: a secondary analysis of a randomised clinical trial

    20 июня, 2025

    CONCLUSION: In a clinical trial of people with GT, a substantial number of participants had multiple tendons affected, as well as concomitant tendon tears and calcification. MRI detected changes were not associated with levels of pain, function or disability. →

    Clinical Trials
  • MiniMax AI Releases MiniMax-M1: A 456B Parameter Hybrid Model for Long-Context and Reinforcement Learning RL Tasks

    19 июня, 2025

    MiniMax AI Releases MiniMax-M1: A 456B Parameter Hybrid Model for Long-Context and Reinforcement Learning RL Tasks Understanding the Target Audience The target audience for MiniMax AI’s release of MiniMax-M1 includes AI researchers, data scientists, software engineers, and business leaders in technology. These individuals are typically well-versed in AI and machine learning concepts and are looking… →

    AI News
  • Efficacy and safety of combined loratadine and mometasone furoate therapy in allergic rhinitis patients

    19 июня, 2025

    CONCLUSION: The combination of loratadine and mometasone furoate effectively alleviates clinical symptoms in patients with allergic rhinitis while demonstrating a favorable safety profile, making it a promising option for clinical use. →

    Clinical Trials
  • A Resilience-Disclosure Intervention for Managing Stigmatised North Korean Refugee Identity: A Quasi-Randomised Controlled Trial

    19 июня, 2025

    North Korean refugee (NKR) undergraduate students in South Korean universities often conceal their NKR identity to mitigate discrimination, a strategy that can impede social connection and access to vital resources for college adjustment. This study evaluates the effectiveness of a resilience-disclosure intervention designed to encourage strategic identity management over complete concealment. In a quasi-randomised controlled… →

    Clinical Trials
  • Long-term Progressive Improvement of Atopic Dermatitis by an Herbal Emollient Plus Combination in a 12-week Clinical Trial

    19 июня, 2025

    Atopic dermatitis is a chronic inflammatory skin disease characterized by flare-ups of inflamed, dry, and itchy skin affecting over 200 million people worldwide. «Emollients plus» containing active cosmetic ingredients such as herbal extracts and phytochemicals have the potential to surpass the efficacy of conventional emollients, while avoiding side effects associated with pharmacological interventions. The reported… →

    Clinical Trials
  • OpenAI Releases an Open‑Sourced Version of a Customer Service Agent Demo with the Agents SDK

    19 июня, 2025

    «`html OpenAI Releases an Open-Sourced Version of a Customer Service Agent Demo with the Agents SDK OpenAI has open-sourced a new multi-agent customer service demo on GitHub, showcasing how to build domain-specialized AI agents using its Agents SDK. This project, titled openai-cs-agents-demo, models an airline customer service chatbot capable of handling a range of travel-related… →

    AI News
  • ReVisual-R1: An Open-Source 7B Multimodal Large Language Model (MLLMs) that Achieves Long, Accurate and Thoughtful Reasoning

    19 июня, 2025

    ReVisual-R1: An Open-Source 7B Multimodal Large Language Model (MLLM) that Achieves Long, Accurate and Thoughtful Reasoning Understanding the Target Audience The target audience for ReVisual-R1 includes AI researchers, data scientists, business managers, and technology enthusiasts interested in the advancements of multimodal language models. Their pain points often revolve around the limitations of existing models in… →

    AI News
Предыдущая страница
1 … 285 286 287 288 289 … 969
Следующая страница